English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/76973
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


GRK2 contribution to the regulation of energy expenditure and brown fat function

AuthorsVila-Bedmar, Rocío ; García-Guerra, Lucía; Nieto-Vázquez, Iria; Mayor Menéndez, Federico ; Lorenzo, Margarita; Murga, Cristina ; Fernández-Veledo, Sonia
Issue Date2012
PublisherFederation of American Societies for Experimental Biology
CitationFASEB Journal 26(8): 3503-3514 (2012)
AbstractObesity is a major health problem and an important risk factor for the development of multiple disorders. Previous studies in our laboratory have revealed that down-regulation of GRK2 decreases age-related adiposity, but the physiological and molecular mechanisms underlying this outcome remain unclear. We evaluate whether the lean phenotype results from a direct effect of GRK2 on energy homeostasis. The study of white adipose tissue (WAT) in wild-type (WT) and GRK2 +/- littermates showed a reduced expression of lipogenic enzymes and enhanced lipolytic rate in adult GRK2 +/- mice. Moreover, hemizygous mice display higher energy expenditure and lower respiratory exchange ratio. Analysis of brown adipose tissue (BAT) from adult GRK2 +/- mice showed a less deteriorated morphology associated with age compared to WT, which is correlated with a higher basal core temperature. BAT from young GRK2 +/- mice showed an increase in gene expression of thermogenesis-related genes. Accordingly, hemizygous mice displayed better thermogenic capacity and exhibited a more oxidative phenotype in both BAT and WAT than WT littermates. Overexpression of GRK2 in brown adipocytes corroborated the negative effect of this kinase in BAT function and differentiation. Collectively, our data point to GRK2 inhibition as a potential tool for the enhancement of brown fat activity, which may have important therapeutic implications for the treatment of obesity and associated metabolic disorders. © FASEB.
Identifiersdoi: 10.1096/fj.11-202267
issn: 0892-6638
e-issn: 1530-6860
Appears in Collections:(CBM) Artículos
(IIBM) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.